Balyasny Asset Management
NARI

Balyasny Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Balyasny Asset Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-83,287
Closed -$4.01M – 3257
2024
Q2 		$4.01M Sell
83,287
-284,701
-77% -$12.6M 0.01% 1270
2024
Q1 		$17.7M Buy
367,988
+184,051
+100% +$9.83M 0.03% 671
2023
Q4 		$11.9M Buy
+183,937
New +$11.1M 0.02% 798
2023
Q1 		– Sell
-5,688
Closed -$362K – 3252
2022
Q4 		$362K Sell
5,688
-325,130
-98% -$23.6M ﹤0.01% 1940
2022
Q3 		$24M Buy
330,818
+203,418
+160% +$15.1M 0.07% 368
2022
Q2 		$8.66M Buy
+127,400
New +$9.16M 0.03% 705
2022
Q1 		– Sell
-103,903
Closed -$9.48M – 2931
2021
Q4 		$9.48M Sell
103,903
-45,664
-31% -$3.91M 0.03% 648
2021
Q3 		$12.1M Sell
149,567
-16,060
-10% -$1.35M 0.05% 499
2021
Q2 		$15.4M Buy
165,627
+139,602
+536% +$13.5M 0.07% 369
2021
Q1 		$2.79M Sell
26,025
-49,973
-66% -$5.19M 0.01% 916
2020
Q4 		$6.63M Buy
+75,998
New +$5.37M 0.04% 566

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Balyasny Asset Management's NARI Position: Q3 2024 in Review

Balyasny Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2024, closing a stake of 83,287 shares — an estimated $4.01M sold.

Balyasny Asset Management first reported a position in NARI in Q4 2020 and held it in 11 quarters. The position peaked at $24M in Q3 2022. 243 funds tracked by Wall St. Rank hold NARI as of Q3 2024.

  • Balyasny Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 83,287 Inari Medical, Inc. Common Stock shares in Q3 2024, an estimated $4.01M.
  • Balyasny Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Balyasny Asset Management's Inari Medical, Inc. Common Stock position peaked at $24M in Q3 2022.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.